The noradrenergic system in Alzheimer and multi-infarct dementias.
AUTOR(ES)
Mann, D M
RESUMO
The number of melanin containing nerve cells of the locus coeruleus and vagus nucleus is reduced in Alzheimer's disease by 60% with decrease of 22% in the protein synthetic capability of remaining cells. These changes are matched by reductions in brain noradrenaline in eight regions, averaging 36%. In multi-infarct dementia, however, all three of these features are unchanged. These findings indicate that degeneration of central noradrenergic nerve cells is a specific aspect of the pathogenic process underlying Alzheimer's disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1083037Documentos Relacionados
- Vascular and Multi-infarct Dementia
- Auditory long latency event-related potentials in Alzheimer's disease and multi-infarct dementia.
- Aetiological considerations and risk factors for multi-infarct dementia.
- Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.
- Analysis of intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease.
